OP0047 Metabolic and Lifestyle Predictors of Inflammatory Polyarthritis in the EPIC-2-NOAR Study
Authors: J.C. Sergeant, S.M.M. Verstappen, C. Morgan, R.N. Luben, A. Bhaniani, S. Anuj, A. MacGregor, N. Wareham, D.P.M. Symmons, K.-T. Khaw, I.N. Bruce
Journal: Annals of the Rheumatic Diseases (2015)

<h3>Background</h3> Linkage of the European Prospective Investigation of Cancer, Norfolk (EPIC-Norfolk) population and the Norfolk Arthritis Register (NOAR), the EPIC-2-NOAR study, has enabled investigation of potential lifestyle predictors of incident inflammatory polyarthritis (IP) [1]. However, potential metabolic predictors of IP have not been as well investigated in this population and have not been considered alongside lifestyle factors. <h3>Objectives</h3> To assess the addition of metabolic factors to an established multivariate lifestyle factor model for incident IP [1], with updated record linkage in EPIC-2-NOAR. <h3>Methods</h3> Data on lifestyle factors (pack-years of smoking (adjusted for never being a smoker), smoking status, alcohol consumption (adjusted for being a teetotaller), body mass index, socio-economic status, self-reported diabetes mellitus (DM), parity and duration of breast feeding) was collected by questionnaire at entry to EPIC-Norfolk. Metabolic factors (serum uric acid, HDL-C, Apo-A1, Apo-B and HbA1c) were measured using a non-fasting blood sample taken at the same time. EPIC-Norfolk participants who subsequently developed IP were identified via linkage with NOAR, a primary care based inception cohort study of early IP. Associations between the metabolic predictors and incident IP were assessed using Cox regression: univariately, adjusting for age and gender, and by adding individual predictors to the existing multivariate Cox models [1], one for all participants (with an interaction term for gender and pack years of smoking) and one for females only. Subjects were followed until development of IP, death, loss to follow-up or May 2014, whichever came first. <h3>Results</h3> Data was available on 25 636 subjects (55% female), including 231 incident cases of IP (66% female). Median (IQR) age at entry to EPIC-Norfolk was 59 (51-67) years, median follow-up was 214 (198-230) months and median time to onset of IP was 79 (34-136) months. No significant association was observed between incident IP and serum uric acid, HDL-C, Apo-A or Apo-B. Baseline HbA1c was positively associated with incident IP in univariate analysis (HR 1.22, 95% CI (1.03, 1.44)), when adjusted for sex and age (HR 1.27 (1.08, 1.49)) and when added to the existing multivariate lifestyle factor models for all (HR 1.26 (1.07, 1.47)) and for females only (HR 1.23 (1.00, 1.52)). Inclusion of HbA1c in the multivariate models led to self-reported DM no longer being significantly associated with IP. <h3>Conclusions</h3> Baseline HbA1c was significantly associated with incident IP, at the expense of self-reported DM in an established multivariate lifestyle factor model. While DM is an established risk factor for IP, HbA1c levels may capture additional information on those in a prediabetic state and could prove a more sensitive marker of future IP. <h3>References</h3> Lahiri et al. Ann Rheum Dis 2014; 73: 219 <h3>Disclosure of Interest</h3> None declared